In most parts of the world anticoagulant therapy with coumarin drugs is controlled by the one-stage prothrombin time test, and because of different sensitivities of the methods to the coumarin defect and different methods of reporting the results, there is difficulty in comparing the level of anticoagulation at one centre with that at another. The provision internationally of a reference preparation of thromboplastin is an attempt to provide a means whereby the degree of anticoagulation determined at different centres may be compared and therapy more uniformly controlled.
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A research standard of thromboplastin, human (67/40) is obtainable, with information about it, on application to the Division of Biological Standards, National Institute for Medical Research, Mill Hill, London. (This is a freeze dried preparation which is stable and which has been characterized in an international collaborative study by Bangham, Briggs, Brozovic, and Denson, 1970.) 
Clotting Time Ratios as an Index of Measurement
The comparative procedure involves the use of the clotting time ratio derived by dividing the clotting time obtained with the patient's plasma by the clotting time obtained with normal plasma. For example, if the patient's plasma has a clotting time of 24 sec and the normal of 12 sec, the clotting time ratio would be2-0.
Collection of Fresh Normal Plasma and Plasma Samples from Patients Stabilized on Anticoagulant Therapy
Blood is collected into one-tenth volume of 3'13% trisodium citrate, the plasma is separated by centrifugation and tested the same day. The research standard (67/40) is normally reconstituted with 3-2 mM CaCl2. If it is the practice to collect blood into one-tenth volume of 3-8 % trisodium citrate for the method under comparison, the same plasma samples may be used for the research standard 67/40 but in this case the reagent should be reconstituted with 4 mM CaCl2.
Test Procedure
Of the thromboplastin reference preparation, 0 4 ml is pipetted into a glass tube and warmed to 37°C. Figure 1 . The best straight line is drawn through the points. It is then possible to calculate the ratios, using the reference thromboplastin preparation, that are equivalent to those using the test thromboplastin preparation. In the example given in Fig. 1 For example, a patient in England might transfer from a hospital using a reagent of thromboplastin sensitivity ratio of 1-5 to a hospital using a reagent whose thromboplastin sensitivity ratio has been determined as 2-2. If it was desired to maintain the patient within a range of ratios from 2-0 to 2-5 (by the test using athromboplastinwhosesensitivityratio is 1-5) then reference to Table II 
